{"date":"2025-01-20","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4735-2025-01-20-2224-1u4n2os","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-01-20","time":"22:24:49","subject":"公告本公司訂定113年現金增資普通股之認股基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-01-20 22:24，「公告本公司訂定113年現金增資普通股之認股基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-01-20-1825-ok2z8z","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-01-20","time":"18:25:19","subject":"公告本公司臺灣士林地方法院112年度金字第3號返還投資款民事訴訟判決主文。","clause":"第2款","fact_date":"2025-01-20","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-01-20 18:25，「公告本公司臺灣士林地方法院112年度金字第3號返還投資款民事訴訟判決主文。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}